118 related articles for article (PubMed ID: 9863027)
1. Somatic genetic alterations in human malignant mesothelioma (review).
Lee WC; Testa JR
Int J Oncol; 1999 Jan; 14(1):181-8. PubMed ID: 9863027
[TBL] [Abstract][Full Text] [Related]
2. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
Murthy SS; Testa JR
J Cell Physiol; 1999 Aug; 180(2):150-7. PubMed ID: 10395284
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the molecular analysis of human malignant mesothelioma.
De Rienzo A; Testa JR
Clin Ter; 2000; 151(6):433-8. PubMed ID: 11211478
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.
Balsara BR; Bell DW; Sonoda G; De Rienzo A; du Manoir S; Jhanwar SC; Testa JR
Cancer Res; 1999 Jan; 59(2):450-4. PubMed ID: 9927061
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal deletion in patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Sugarbaker DJ
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
[TBL] [Abstract][Full Text] [Related]
6. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.
Bell DW; Jhanwar SC; Testa JR
Cancer Res; 1997 Sep; 57(18):4057-62. PubMed ID: 9307293
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma.
De Rienzo A; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2000 Jul; 28(3):337-41. PubMed ID: 10862040
[TBL] [Abstract][Full Text] [Related]
8. Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region.
Pylkkänen L; Sainio M; Ollikainen T; Mattson K; Nordling S; Carpén O; Linnainmaa K; Husgafvel-Pursiainen K
Oncol Rep; 2002; 9(5):955-9. PubMed ID: 12168054
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular genetic changes in malignant mesothelioma.
Musti M; Kettunen E; Dragonieri S; Lindholm P; Cavone D; Serio G; Knuutila S
Cancer Genet Cytogenet; 2006 Oct; 170(1):9-15. PubMed ID: 16965949
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
11. Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.
Taguchi T; Jhanwar SC; Siegfried JM; Keller SM; Testa JR
Cancer Res; 1993 Sep; 53(18):4349-55. PubMed ID: 8364929
[TBL] [Abstract][Full Text] [Related]
12. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
13. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.
Shivapurkar N; Virmani AK; Wistuba II; Milchgrub S; Mackay B; Minna JD; Gazdar AF
Clin Cancer Res; 1999 Jan; 5(1):17-23. PubMed ID: 9918198
[TBL] [Abstract][Full Text] [Related]
14. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
[TBL] [Abstract][Full Text] [Related]
15. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
[TBL] [Abstract][Full Text] [Related]
18. Homozygous deletions within 9p21-p22 identify a small critical region of chromosomal loss in human malignant mesotheliomas.
Cheng JQ; Jhanwar SC; Lu YY; Testa JR
Cancer Res; 1993 Oct; 53(20):4761-3. PubMed ID: 8402655
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetic progression on nasopharyngeal carcinoma].
Shao JY; Zeng WF; Zeng YX
Ai Zheng; 2002 Jan; 21(1):1-10. PubMed ID: 12500388
[TBL] [Abstract][Full Text] [Related]
20. Interphase fish analysis of cell cycle genes in asbestos-treated human mesothelial cells (HMC), SV40-transformed HMC (MeT-5A) and mesothelioma cells (COLO).
Dopp E; Poser I; Papp T
Cell Mol Biol (Noisy-le-grand); 2002; 48 Online Pub():OL271-7. PubMed ID: 12643444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
